OCT 11, 2016 8:00 AM PDT

Pro-Enkephalin: A Novel New Biomarker for Assessment of Kidney Function, Early Prediction and Identification of Acute Kidney Injury

Speaker
  • Professor of Medicine , UC San Diego Director, Coronary Care Unit and Heart Failure Program, Veterans Affairs San Diego Healthcare System
    BIOGRAPHY

Abstract
DATE:  October 11, 2016
TIME:  8:00am PT, 11:00 ET

Chronic Renal Dysfunction (CKD) and Acute Kidney Injury (AKI) are increasing in prevalence today and can be escalated due to diseases such as diabetes, surgical procedures as well as nephrotoxic treatments.  Acute kidney injury (AKI) represents an acute decline in renal function that leads to structural changes. AKI is associated with increased mortality, length of hospital stay and costs .  This unfavorable outcome might be tied to the late detection of AKI when the elevation of serum creatinine (SCr) is used.  No currently available biomarkers have been demonstrated to meet clinical needs for prediction, diagnosis and management.  

ProEnkephalin (PENK) is an endogenous opioid hormone that has been demonstrated to be released in proportion to increasing renal distress and dysfunction.  Blood levels of PENK have been assessed now in thousands of patients and in multiple studies of both CKD and AKI.  This data will be reviewed by Dr. Alan Maisel, a leader in the field of novel protein biomarkers.
 
Learning Objectives: 
  • Characterize the clinical challenge of chronic and acute kidney injury (AKI) and the limitations for predicting, diagnosing and managing AKI
  • Review ProEnkephalin, its function and role as an endogenous opioid hormone, and its relationship to renal function
  • Review recently published data in European and North American cohorts examining ProEnkephalin levels in predicting outcomes in chronic renal function and acute kidney injury.

Show Resources
You May Also Like
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAY 24, 2022 11:00 AM PDT
MAY 24, 2022 11:00 AM PDT
Date: May 24, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 7:00pm (CEST) NGS tumor profiling has become the mainstay of modern cancer therapy. Several NCCN-guided and FDA-approved therapies are c...
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
Loading Comments...
Show Resources